Ali Behbahani
Independent DirectorDr. Ali Behbahani, M.B.A & M.D, is Partner & Co-Head of Healthcare of New Enterprise Associates, Inc. Dr. Behbahani joined the New Enterprise Associates, Inc. in 2007. Dr. Behbahani focuses on Seed/Early, Growth, Healthcare, US. Dr. Behbahani was General Partner of New Enterprise Associates, Inc. Dr. Behbahani was Partner of New Enterprise Associates, Inc. from November 06, 2013. Dr. Behbahani is Director of Oculeve, Inc. Dr. Behbahani is Independent Director of CRISPR Therapeutics AG from April 2015. Dr. Behbahani joined the CRISPR Therapeutics AG in April 2015. Dr. Behbahani is Managing Director of ClarVista Medical, Inc. Dr. Behbahani is Director of Rotation Medical Inc. Dr. Behbahani is Director of Prospex Medical III, Inc. Dr. Behbahani is Director of Cardionomic, Inc. Dr. Behbahani is Independent Director of Black Diamond Therapeutics, Inc. from December 2018. Dr. Behbahani is Director of CRISPR Therapeutics, Inc. from May 2015. Dr. Behbahani is Independent Chairman of Nkarta, Inc. from August 2019. Dr. Behbahani was Director of Nkarta, Inc. from October 2015 to August 2019. Dr. Behbahani is Independent Director of Korro Bio, Inc. from November 03, 2023. Dr. Behbahani is Director of 858 Therapeutics, Inc. Dr. Behbahani is Independent Director of Monte Rosa Therapeutics, Inc. from April 2020. Dr. Behbahani is Director of Stablix, Inc. Dr. Behbahani is Director of Tune Therapeutics, Inc. from 2022. Dr. Behbahani is Director of FirstLight Bio, Inc. Dr. Behbahani is Partner & Co-Head of Healthcare of NEA Management Company LLC. Dr. Behbahani was Healthcare Investment Banking Analyst of Lehman Brothers Inc. Dr. Behbahani was Board Observer of Trillium Therapeutics Inc. from February 06, 2020. Dr. Behbahani was Consultant of Business Development of The Medicines Company. Dr. Behbahani was Independent Director of Nevro Corp. from September 2014 to March 18, 2019. Dr. Behbahani was employed at Nevro Corp. from September 2014 to March 18, 2019. Dr. Behbahani was Independent Director of Genocea Biosciences, Inc. from February 12, 2018 to May 25, 2022. Dr. Behbahani was employed at Genocea Biosciences, Inc. from February 12, 2018 to May 25, 2022. Dr. Behbahani was Independent Non-Executive Director of Adaptimmune Therapeutics plc from February 12, 2015 to November 14, 2025. Dr. Behbahani was employed at Adaptimmune Therapeutics plc until November 14, 2025. Dr. Behbahani was Independent Director of CVRx, Inc. from July 2013 to September 3 , 2024. Dr. Behbahani was employed at CVRx, Inc. from July 2013 to September 3 , 2024. Dr. Behbahani was Director of Solace Therapeutics, Inc. Dr. Behbahani was Independent Director of Minerva Surgical, Inc. from May 2011 to 2024. Dr. Behbahani was employed at Minerva Surgical, Inc. until 2024. Dr. Behbahani was Independent Director of Arcellx, Inc. from January 2015 to April 28, 2026. Dr. Behbahani was employed at Arcellx, Inc. until April 28, 2026. Dr. Behbahani was Venture Associate of Morgan Stanley Venture Partners. Dr. Behbahani was Independent Director of Oyster Point Pharma, Inc. from July 30, 2021. Dr. Behbahani was Independent Chairperson of the Board of Oyster Point Pharma, Inc. from October 08, 2020 to July 30, 2021. Dr. Behbahani was Independent Director of Oyster Point Pharma, Inc. from July 2017 to October 08, 2020. Dr. Behbahani has B.S. in Electrical Engineering, Biomedical Engineering & Chemistry from Duke University, M.B.A. from University of Pennsylvania - The Wharton School, M.D. from Perelman School of Medicine at the University of Pennsylvania.
Positions
- Company NameBlack Diamond Therapeutics, Inc.Stock CodeBDTXPositionIndependent DirectorColleagues
- MAMark A. VellecaCEO, President & Chairman
- BHBrent Hatzis-SchochCOO & General Counsel
- SYSergey YurasovChief Medical Officer
- EBElizabeth BuckCo-Founder & Chief Scientific Officer
- EJErika JonesPrincipal Financial Officer, Principal Accounting Officer, SVP of Finance & Corporate Controller
- ABAli BehbahaniIndependent Director
- GEGarry E. MenzelIndependent Director
- KDKapil DhingraIndependent Director
- SKSamarth KulkarniLead Independent Director
- Company NameNkarta, Inc.Stock CodeNKTXPositionIndependent ChairmanColleagues
- PJPaul J. HastingsCEO & Director
- ABAli BehbahaniIndependent Chairman
- NMNadir MahmoodPresident and Principal Accounting & Financial Officer
- SRShawn RoseChief Medical Officer and Head of Research & Development
- MPMichael Philip DybbsIndependent Director
- LDLeone D. PattersonIndependent Director
- ZSZachary ScheinerIndependent Director
- Company NameKorro Bio, Inc.Stock CodeKRROPositionIndependent DirectorColleagues
- RARam AiyarCEO, President, Interim CFO, Principal Financial Officer & Director
- NBNessan BerminghamCo-Founder & Independent Chairman of the Board
- JFJean-Francois FormelaCo-Founder & Director
- LVLoic VincentChief Scientific Officer
- JMJeffrey M. CerioSenior VP, General Counsel & Corporate Secretary
- AFAndrew FraleyCo-Founder & Advisor
- TRTimothy R. PearsonIndependent Director
